Washington Patent of the Month – January 2024

Know Labs, Inc., a medical diagnostics technology company, has recently been granted a patent for a non-invasive approach to detecting analytes within target samples. This type of technology allows for a broad range of applications – but Know Labs is currently focused on improved blood glucose monitoring methods.

Standard approaches to monitor blood glucose involve gathering bodily fluids via pricking your finger or lab-based blood draws. Existing non-invasive approaches are known to lack specificity to the desired analyte – in this case, glucose. Know Lab’s new, non-invasive approach achieves greater specificity and accuracy than ever before.

The method involves the use of a sophisticated sensor system with transmit and receive antennas, each carefully designed for optimal functionality. These antennas operate in the radio or microwave frequency range, ranging from about 10 kHz to about 100 GHz. The unique design includes parallel side edges, varying geometries at the ends, and intentional decoupling between the transmit and receive elements.

The key to its success lies in the system’s ability to non-invasively detect analytes within a target, such as glucose in biological tissues. Unlike traditional invasive methods, this technology promises specificity, reduced interference, and simplified placement, marking a significant leap forward in patient comfort and overall effectiveness.

Once the analytes are detected, a processor takes charge, determining their presence or amount based on the response received. What sets this invention apart is its smart notification system. The processor evaluates predefined criteria and, upon detecting a specific condition, triggers a notification. This notification can be presented through various means, including visual, aural, or tactile components, either directly at the sensor or on an external device.

The potential applications are vast, from monitoring glucose levels to detecting various analytes in different targets, opening doors to a new era of personalized and non-invasive healthcare. For instance, a notification indicating low blood sugar levels can be crucial for individuals managing diabetes, allowing for timely intervention.

This groundbreaking invention aligns with the growing demand for non-invasive healthcare technologies, promising not only accurate analyte detection but also real-time, user-friendly notifications. Know Labs’ commitment to pushing the boundaries of innovation positions this method as a beacon of hope for more accessible and efficient healthcare monitoring.

Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.

Who We Are:

Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.

Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.

Recent Posts